Syngene Acquires Its First Manufacturing Facility In The US
The state-of-the-art biologics facility, acquired by Syngene USA Inc., a wholly owned subsidiary of Syngene, from Emergent ...
Le Lézard2d
Unveiling Pharma Market Potential: DelveInsight's Strategic Insights into the Rapidly Expanding MASH Landscape in Asia
DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...
Syngene International: Syngene Acquires its First Manufacturing Facility in the US
Expected to enhance global innovator flexibility with biologics drug substance facility in Baltimore BANGALORE, India, March ...
Yahoo Finance5d
Syngene Acquires its First Manufacturing Facility in the US
It strengthens our offering for animal health clients looking for USDA approval for their products. Most importantly, it increases the options we can offer our global customers, providing ...
Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other ...